AmeriServ Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

AmeriServ Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,812	Closed	-$953K	–	73
2018 Q3	$953K	Buy	7,812 +1,928	+33%	+$227K	1.19%	18
2018 Q2	$646K	Buy	5,884 +95	+2%	+$10.2K	0.87%	28
2018 Q1	$618K	Buy	5,789 +3,156	+120%	+$350K	0.7%	29
2017 Q4	$831K	Buy	+2,633	New	+$281K	0.8%	24
2015 Q3	–	Sell	-75	Closed	-$9K	–	103
2015 Q2	$9K	Buy	+75	New	+$8.98K	0.01%	129
2014 Q1	–	Sell	-8,520	Closed	-$645K	–	144
2013 Q4	$645K	Buy	8,520 +1,140	+15%	+$80.9K	0.38%	78
2013 Q3	$516K	Buy	7,380 +855	+13%	+$56K	0.33%	95
2013 Q2	$378K	Buy	+6,525	New	+$377K	0.24%	118

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

AmeriServ Wealth Advisors's IBB Position: Q4 2018 in Review

AmeriServ Wealth Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 7,812 shares — an estimated $953K sold.

AmeriServ Wealth Advisors first reported a position in IBB in Q2 2013 and held it in 8 quarters. The position peaked at $953K in Q3 2018. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

AmeriServ Wealth Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
AmeriServ Wealth Advisors sold 7,812 iShares Biotechnology ETF shares in Q4 2018, an estimated $953K.
AmeriServ Wealth Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 8 quarters.
AmeriServ Wealth Advisors's iShares Biotechnology ETF position peaked at $953K in Q3 2018.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on AmeriServ Wealth Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.